OCULAR THERAPEUTIX revenue breakdown overview

OCULAR THERAPEUTIX revenue for the last year amounted to 57.87 M CHF, the most of which — 57.64 M CHF — came from its highest performing source at the moment, Bioresorbable Hydrogel-based Formulation Technology, the year earlier bringing 48.72 M CHF. The greatest contribution to the revenue figure was made by United States — last year it brought OCULAR THERAPEUTIX 57.87 M CHF, and the year before that — 49.21 M CHF.